Martin Blomberg Jensen

Martin Blomberg Jensen is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, and serves as consultant and head of research at the Department of Endocrinology and Internal Medicine, Copenhagen University Hospital – Herlev-Gentofte. He leads the section of Translational Endocrinology and is an EAA-certified specialist in Andrology since 2012.

His research focuses on endocrine crosstalk between the pituitary, gonads, and skeleton, with particular expertise in mineral disorders. Dr. Jensen graduated with an MD from the University of Copenhagen in 2006 and earned his Doctor of Medical Sciences (DMSc) in 2014.

His recent publication record (2025) demonstrates significant contributions to understanding calcium homeostasis, vitamin D metabolism, and reproductive endocrinology. His work bridges clinical observations with translational research, particularly examining mineral disorders in relation to fertility and endocrine function.

Dr. Jensen has secured research funding from multiple prestigious sources:

• Novo Nordisk Foundation
• MD Sofus Carl Emil and wife Olga Doris Friis Scholarship
• Research Fund Rigshospitalet
• Aase og Ejnar Danielsens Foundation
• Candy foundation
• Beckett Foundation
• innovationsfonden

His professional activities include:

• CEO and founder of XY therapeutics Aps (Region Hovedstaden spin-out)
• Advisory board roles at Faes Pharma, Novo Nordisk, and Vertex
• Author of vitamin D textbook for Elsevier
• Speaker engagements for Gedeon Richter, Merck, and Amgen
• 2025 Board of Directors appointment at Danish Diabetes and Endocrinology Academy

Dr. Jensen maintains active research collaborations, including ongoing discussions with Repronovo, and has published 39 research outputs that have attracted attention from 17 news outlets.